NCT02179606View on ClinicalTrials.gov

Clinical Study to Evaluate the Efficacy and Safety of Dermalax Implant Plus

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

March 31, 2014

Conditions
Correction of Nasolabial Folds
Interventions
DEVICE

Dermalax Implant Plus

Dermalax implant plus injection into one nasolabial fold(NFL) of one side of the face(blinded, split-face study design) in the initial treatment period.

DEVICE

Restylane Sub-Q

Restylane Sub-Q injection into one nasolabial fold(NFL) of one side of the face(blinded, split-face study design) in the initial treatment period.

Trial Locations (2)

Unknown

Chung-ang University Hospital, Seoul

Eulji General Hospital, Seoul

All Listed Sponsors
lead

Across Co., Ltd.

INDUSTRY

NCT02179606 - Clinical Study to Evaluate the Efficacy and Safety of Dermalax Implant Plus | Biotech Hunter | Biotech Hunter